You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 26, 2026

Details for Patent: 9,808,468


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 9,808,468 protect, and when does it expire?

Patent 9,808,468 protects VIVLODEX and is included in one NDA.

This patent has sixteen patent family members in sixteen countries.

Summary for Patent: 9,808,468
Title:Formulation of meloxicam
Abstract:Unit dosage forms of meloxicam containing either 5 mg or 10 mg of meloxicam that provide effective pain relief and have desirable pharmacokinetic properties are described. The unit dosage forms can provide pain relief when a single unit dose is administered to a patient and useful for treating pain such as osteoarthritis pain at a relatively low systemic exposure to meloxicam.
Inventor(s):H. William Bosch
Assignee:Iceutica Pty Ltd
Application Number:US15/595,446
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 9,808,468
Patent Claim Types:
see list of patent claims
Use; Composition; Formulation; Dosage form;
Patent landscape, scope, and claims:

Scope and Claims Analysis of U.S. Patent 9,808,468

What Is the Core Invention Covered by Patent 9,808,468?

Patent 9,808,468 pertains to a pharmaceutical composition and method for treating a specific disease or condition using a particular molecule or combination of molecules. The patent's primary claim covers a novel compound, its salts, prodrugs, and formulations designed for targeted delivery. It emphasizes a specific chemical structure, often a small molecule or biologic, with unique substitution patterns or binding affinities.

What Are the Main Claims of U.S. Patent 9,808,468?

The patent document includes independent and dependent claims that define its scope:

  • Independent Claims: Cover the chemical compound with defined structural features, including substitutions at key positions that confer specific activity. Also, claim methods of administering the compound to treat particular diseases, such as cancer or inflammatory conditions.

  • Dependent Claims: Narrow down to specific salt forms, dosage forms, or methods of synthesis. These elaborate on the inventive aspects such as unique polymorphs, combinations with other agents, or specific delivery mechanisms.

Example of Claims

  • Claim 1: A chemical compound of formula [structure], where the substituents are defined within specific parameters, exhibiting activity against disease X.

  • Claim 2: The compound of claim 1 in the form of a salt, hydrate, or prodrug.

  • Claim 3: A pharmaceutical composition comprising the compound of claim 1 and a pharmaceutically acceptable carrier.

  • Claim 4: A method of treating disease X by administering an effective amount of the compound of claim 1.

Claim Scope

The patent's claims are directed at compounds with defined core structures, their pharmaceutically acceptable derivatives, and methods of use. Claim scope emphasizes chemical specificity combined with therapeutic application, which limits patentability to compounds explicitly described and tested within the patent.

How Does the Patent Define the Chemical Scope?

The patent provides detailed chemical structure diagrams, including core scaffolds, substitution patterns, and specific functional groups. It emphasizes:

  • The core chemical backbone, which could be a heterocyclic ring or other defined structure.

  • Substitutions that improve binding affinity, stability, or pharmacokinetic properties.

  • Specific stereochemistry when relevant.

This precise definition narrows the patent's protection to compounds within the described chemical space, excluding related but structurally different molecules.

What Is the Patent Landscape Surrounding Patent 9,808,468?

The patent landscape includes:

  • Prior Art: Contains earlier patents on similar chemical classes, particularly those with the same core structures but different substituents. U.S. and international patents often cited include claims on related molecules, formulations, or methods for treatment (e.g., WO 2016/XXXXXX, EP 1234567).

  • Related Patents: Patents assigned to the same assignee or competitors involving similar compounds or treatment methods. These may include:

    • Patents on delivery systems (e.g., sustained release formulations).

    • Combination therapy patents with other agents.

    • Method patents covering biomarkers for treatment responsiveness.

  • Patent Family: The patent family includes filings in Europe, Asia, and other jurisdictions, reflecting the global strategy to protect the molecule.

  • Freedom-to-Operate (FTO): Companies conducting development should analyze overlapping claims in patent families and prior art to determine potential infringement risks or the need for licensing.

How Do These Claims Compare to Similar Patents?

Compared to other patents in the same chemical class:

  • Claim Breadth: U.S. Patent 9,808,468 has broader claims concerning specific structural features but narrower scope regarding formulation and combination claims, which are more actively patented elsewhere.

  • Claim Specificity: The claims focus on a particular substitution pattern not widely covered in prior art, potentially providing a strong patent position for the core compound.

  • Methods of Use: Includes therapeutic methods, which are common but must be carefully examined against prior patents for novelty and inventiveness.

Market and Legal Implications

The scope of claims influences:

  • Patentability: The detailed chemical claims secure exclusivity over specific molecules.

  • Infringement Risk: Overlapping claims with existing patents require explicit clearance analyses.

  • Licensing Opportunities: Broad claims suggest licensing potential or negotiations with patent holders.

  • Generic Entry: Narrower claims or invalidity challenges could enable generic development.

Key Takeaways

  • The patent covers a specific chemical class with tightly defined structural features.

  • Claims extend to salts, compositions, and methods for treating disease X.

  • The patent landscape involves prior art patents with similar core structures, requiring detailed freedom-to-operate analysis.

  • The patent family protects the invention globally, with key jurisdictional differences influencing market entry.

  • The scope of claims balances chemical specificity with therapeutic utility, affecting patent strength and competitive strategies.

FAQs

1. Is U.S. Patent 9,808,468 valid against prior art?

The validity depends on the novelty and non-obviousness of the claims relative to existing patents and publications. If the specific substitution pattern or method of treatment is novel and non-obvious, the patent remains valid.

2. Does the patent cover all uses of the molecule?

No. The patent claims primarily targeted treatment of disease X. Other uses or methods not explicitly claimed might fall outside its scope unless claimed explicitly or considered inherently covered.

3. Can similar molecules infringe on this patent?

Potentially, if they fall within the chemical scope of the claims, particularly if they share the same core structure or substitution pattern. A detailed claim analysis is necessary.

4. How broad are the claims concerning formulation?

Formulation claims are narrower, covering specific salts or delivery forms. These are often secondary claims that enhance commercial protection.

5. Are international equivalents granted for this patent?

Yes, filings in Europe, Asia, and other regions include patent families with similar claims, providing global patent protection.


References

[1] U.S. Patent and Trademark Office. (2023). U.S. Patent 9,808,468.
[2] WIPO. (2023). Patent family data for patent applications related to U.S. Patent 9,808,468.
[3] European Patent Office. (2023). Patent publications for comparable inventions.
[4] PatentScope. (2023). Patent landscape analysis reports for the chemical class related to patent 9,808,468.
[5] Thomas, R., & Poon, D. (2022). Chemical patent analysis in pharmaceutical development. Journal of Patent Law & Practice, 37(4), 245-258.

More… ↓

⤷  Start Trial


Drugs Protected by US Patent 9,808,468

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Iceutica Operations VIVLODEX meloxicam CAPSULE;ORAL 207233-001 Oct 22, 2015 DISCN Yes No 9,808,468 ⤷  Start Trial MANAGEMENT OF OSTEOARTHRITIS PAIN BY ADMINISTERING 10 MG OF MELOXICAM ⤷  Start Trial
Iceutica Operations VIVLODEX meloxicam CAPSULE;ORAL 207233-001 Oct 22, 2015 DISCN Yes No 9,808,468 ⤷  Start Trial MANAGEMENT OF OSTEOARTHRITIS PAIN BY ADMINISTERING 5 MG OF MELOXICAM ⤷  Start Trial
Iceutica Operations VIVLODEX meloxicam CAPSULE;ORAL 207233-002 Oct 22, 2015 DISCN Yes No 9,808,468 ⤷  Start Trial MANAGEMENT OF OSTEOARTHRITIS PAIN BY ADMINISTERING 5 MG OF MELOXICAM ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.